Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Juvenile spondyloarthropathy.

Shirley M L Tse1, Ronald M Laxer

  • 1Department of Pediatrics, Hospital for Sick Children, University of Toronto, Ontario, Canada. shirley.tse@sickids.ca

Current Opinion in Rheumatology
|June 24, 2003
PubMed
Summary

Juvenile-onset spondyloarthropathies are increasingly recognized pediatric disorders. Current treatments offer symptom relief, but further research is needed for disease modification in juvenile arthritis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Topical Roflumilast for Pediatric Morphea.

Journal of cutaneous medicine and surgery·2026
Same author

Baricitinib in two paediatric patients with coatomer subunit alpha (COPA) syndrome: A case series and literature review.

Modern rheumatology case reports·2026
Same author

Pediatric morphea: MRI evaluation of superficial and deep tissue involvement and impact in clinical practice.

Pediatric radiology·2026
Same author

Canadian Rheumatology Association/Spondyloarthritis Research Consortium of Canada Living Treatment Recommendations for the Management of Axial Spondyloarthritis: Update #1.

The Journal of rheumatology·2026
Same author

Differentiating Periodic Fever, Aphthous Stomatitis, Pharyngitis, Cervical Adenitis (PFAPA) and Syndrome of Undifferentiated Recurrent Fever (SURF): A Comparative Study of Clinical Features, Treatment Response, and Remission.

The Journal of rheumatology·2026
Same author

Intravenous immunoglobulin for the treatment of morphea in pediatric patients: A case series.

JAAD case reports·2026

Area of Science:

  • Pediatric Rheumatology
  • Immunology

Background:

  • Juvenile-onset spondyloarthropathies (JOSpA) encompass pediatric disorders featuring joint and enthesis inflammation.
  • New classification criteria enhance disease recognition and understanding.

Purpose of the Study:

  • To review recent advancements in JOSpA, covering etiology, clinical features, treatments, and prognosis.
  • To highlight the impact of improved recognition on clinical trial design and evaluation.

Main Methods:

  • Literature review of recent studies on JOSpA.
  • Analysis of etiological factors, clinical manifestations, and therapeutic outcomes.
  • Evaluation of prognosis and disease modification potential.

Main Results:

  • Increased recognition of JOSpA due to new classification criteria.
  • Current therapeutic strategies primarily focus on symptomatic management.
  • Systematic treatment trials are evaluating pediatric-specific clinical outcomes.

Conclusions:

  • JOSpA requires further investigation to explore disease-modifying treatment options.
  • Enhanced understanding facilitates more rigorous clinical research in pediatric rheumatology.
  • Symptomatic control is the current standard, necessitating future research for long-term disease management.

Related Experiment Videos